The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Bilateral thoracic ESP block on the day of the transplantation with a subsequent catheterization will be suggested for the patients. In case of their written consent for the participation in the study this procedure will be performed on the day of the operation. 0.2% ropivacaine is going to be used throughout all the perioperative period.
Universal Hospital Oberig
Kyiv, Ukraine
RECRUITINGPain reduction postoperative
Pain assessment with scores
Time frame: from enrollment to the 2nd postoperative day
Opioid reduction intraoperatively
The amount of intraoperative fentanyl
Time frame: from enrollment to the end of the operation
Need for opioids postoperatively
Need for opioids postoperatively
Time frame: from enrollment to the 2nd postoperative day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.